Global PET Radiopharmaceuticals Market - Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026)

Category : Pharmaceutics

Published On : Dec 2020

The global PET Radiopharmaceuticals Market size was valued at US$XXX.X million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of XX.X% for the forecast period ending 2026 reaching a Market value of US$XXX.X million.

From the perspective of the Product Type market segmentation, the report covers:
F-18
Ru-82
Others

This segment of the PET Radiopharmaceuticals Market is expected to drive the growth in the coming years owing to various positive trends.

The Segment study of Application includes an analysis of
Oncology
Cardiology
Neurology
Others

The market segments are identified and analyzed keeping in mind the PET Radiopharmaceuticals Market ecosystem as a whole

To learn more about this report, request a free sample copy

Given that the ecosystem of the market is vast with its interconnectivities and relatedness, market players and the decision makers therein would need specific data in a more in-depth manner.
We suggest a conversation with our Analyst to map the relevancy of the report and its data more appropriately

Report Scope from a business-objective perspective, includes an understanding required for formulating business strategies like:
--> New product launch
--> New client acquisition
--> New opportunity mapping (market level and geography level)
--> Competitive benchmarking
--> Cost optimization strategies
--> Inorganic expansion plans

Competitive Landscape
The PET Radiopharmaceuticals Market is fairly fragmented. While the key companies continue to drive innovation and, in most cases, adopt digital transformations, the overall competitive ecosystem is dominated by Market leaders as well as emerging players with niche offerings

The PET Radiopharmaceuticals Market report profiles some of the key market players while reviewing significant market developments and strategies adopted by them.
While looking at Organic and Inorganic strategies separately, the report studies not only outlook based (short-mid-long term), but also strategy based (strategic vs operational) market activity.

Key companies profiled in this market report include:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

While most of the Key Profiles are Market Leaders, the profiling is based on covering the market ecosystem. Based on the Market that a client operates in, we customize the list to make the CI data more relevant for the analysis. Companies profiles usually include:
Company Overview
Performance Overview
Products / Services Overview
Recent Developments

Regional Analysis
From a geographic segmentation perspective, the report focuses on the regions that have a material and significant effect on the overall market value. The broad level coverage of the report includes the regions and key countries within the regions of Global, North America, Europe, APAC, MEA

The Covid19 pandemic has transformed the market landscape. The market ecosystem has taken a directional shift in the way supply-side of the market is accessed. The report covers the aftermath of the Covid19 catastrophe

Report Customization
Our dynamic and proprietary data-mining technology has given us the flexibility to maintain both precision and speed while delivering exclusive and custom insights to our clients.
We conduct customization of the Research data on all key fronts – Regional, Segment, Competitive landscape level. For every report-purchase, we offer 50 analyst-hours of free customization.

Frequently Asked Questions (FAQs)

Which Regions are Covered in This Report?

The broad level coverage of the report includes the regions and key countries within the regions of Global, North America, Europe, APAC, MEA etc.

How Covid-19 is Impacting on this Market?

The Covid19 pandemic has transformed the market landscape. The market ecosystem has taken a directional shift in the way supply-side of the market is accessed.

Is This Report Customizable?

Yes, we conduct customization of the Research data on all key fronts – Regional, Segment, Competitive landscape level. For every report-purchase, we offer 50 analyst-hours of free customization.

Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency

Chapter 2. Executive Summary
2.1 PET Radiopharmaceuticals Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 PET Radiopharmaceuticals Market Business Segmentation
2.5 PET Radiopharmaceuticals Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics

Chapter 3. Strategic Analysis
3.1 PET Radiopharmaceuticals Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 PET Radiopharmaceuticals Market Digital Transformation

Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News

Chapter 5. Segmentation & Statistics
5.1 Segmentation Overview
5.2 Demand Forecast & Market Sizing

Global PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Global PET Radiopharmaceuticals Market by Application 2019 - 2026

North America PET Radiopharmaceuticals Market by Product Type 2019 - 2026
North America PET Radiopharmaceuticals Market by Application 2019 - 2026

United States PET Radiopharmaceuticals Market by Product Type 2019 - 2026
United States PET Radiopharmaceuticals Market by Application 2019 - 2026

Canada PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Canada PET Radiopharmaceuticals Market by Application 2019 - 2026

Mexico PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Mexico PET Radiopharmaceuticals Market by Application 2019 - 2026

Europe PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Europe PET Radiopharmaceuticals Market by Application 2019 - 2026

United Kingdom PET Radiopharmaceuticals Market by Product Type 2019 - 2026
United Kingdom PET Radiopharmaceuticals Market by Application 2019 - 2026

France PET Radiopharmaceuticals Market by Product Type 2019 - 2026
France PET Radiopharmaceuticals Market by Application 2019 - 2026

Italy PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Italy PET Radiopharmaceuticals Market by Application 2019 - 2026

Germany PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Germany PET Radiopharmaceuticals Market by Application 2019 - 2026

Spain PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Spain PET Radiopharmaceuticals Market by Application 2019 - 2026

Rest of Europe PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Rest of Europe PET Radiopharmaceuticals Market by Application 2019 - 2026

APAC PET Radiopharmaceuticals Market by Product Type 2019 - 2026
APAC PET Radiopharmaceuticals Market by Application 2019 - 2026

China PET Radiopharmaceuticals Market by Product Type 2019 - 2026
China PET Radiopharmaceuticals Market by Application 2019 - 2026

India PET Radiopharmaceuticals Market by Product Type 2019 - 2026
India PET Radiopharmaceuticals Market by Application 2019 - 2026

Japan PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Japan PET Radiopharmaceuticals Market by Application 2019 - 2026

South Korea PET Radiopharmaceuticals Market by Product Type 2019 - 2026
South Korea PET Radiopharmaceuticals Market by Application 2019 - 2026

Rest of APAC PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Rest of APAC PET Radiopharmaceuticals Market by Application 2019 - 2026

MEA PET Radiopharmaceuticals Market by Product Type 2019 - 2026
MEA PET Radiopharmaceuticals Market by Application 2019 - 2026

South Africa PET Radiopharmaceuticals Market by Product Type 2019 - 2026
South Africa PET Radiopharmaceuticals Market by Application 2019 - 2026

GCC Countries PET Radiopharmaceuticals Market by Product Type 2019 - 2026
GCC Countries PET Radiopharmaceuticals Market by Application 2019 - 2026

Rest of MEA PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Rest of MEA PET Radiopharmaceuticals Market by Application 2019 - 2026

LatAm PET Radiopharmaceuticals Market by Product Type 2019 - 2026
LatAm PET Radiopharmaceuticals Market by Application 2019 - 2026

Brazil PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Brazil PET Radiopharmaceuticals Market by Application 2019 - 2026

Argentina PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Argentina PET Radiopharmaceuticals Market by Application 2019 - 2026

Rest of LatAm PET Radiopharmaceuticals Market by Product Type 2019 - 2026
Rest of LatAm PET Radiopharmaceuticals Market by Application 2019 - 2026



Chapter 6. Market Use case studies

Chapter 7. KOL Recommendations

Chapter 8. Investment Landscape
8.1 PET Radiopharmaceuticals Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity

Chapter 9. PET Radiopharmaceuticals Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies

Chapter 10. Company Profiles
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Company Profile data includes:
 Company Overview
 Performance Overview
 Products / Services Overview
 Recent Development and other Analysis


Chapter 11. Appendix
11.1 About In4Research
11.2 In4Research Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us


Shop Now

Buy Now

Follow Us

Buy Now